We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-13.55%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$244B
AUM Growth
-$56.4B
Cap. Flow
-$9.23B
Cap. Flow %
-3.79%
Top 10 Hldgs %
13.08%
Holding
11,816
New
1,263
Increased
3,669
Reduced
5,058
Closed
1,051

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$641M
2
MSFT icon
Microsoft
MSFT
+$477M
3
ACN icon
Accenture
ACN
+$354M
4
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$332M
5
CVX icon
Chevron
CVX
+$304M

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Healthcare 7.02%
3 Financials 6.95%
4 Consumer Discretionary 5.19%
5 Industrials 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGRYW
9626
DELISTED
Berkshire Grey, Inc. Warrant
BGRYW
$2K ﹤0.01%
8,319
-7,125
-46% -$2.1K
CRECW
9627
DELISTED
Crescera Capital Acquisition Corp Warrant
CRECW
$2K ﹤0.01%
11,801
GSRMU
9628
DELISTED
GSR II Meteora Acquisition Corp. Unit
GSRMU
$2K ﹤0.01%
+210
New +$2.12K
PBEE
9629
DELISTED
Invesco PureBeta FTSE Emerging Markets ETF
PBEE
$2K ﹤0.01%
83
-27
-25% -$650
PBDM
9630
DELISTED
Invesco PureBeta FTSE Developed ex-North America ETF
PBDM
$2K ﹤0.01%
100
+33
+49% +$829
HEXO
9631
DELISTED
HEXO Corp. Common Shares
HEXO
$2K ﹤0.01%
544
-487
-47% -$2.33K
UVDV
9632
DELISTED
UVA Dividend Value ETF
UVDV
$2K ﹤0.01%
+177
New +$1.75K
RJAC
9633
DELISTED
Jackson Acquisition Company
RJAC
$2K ﹤0.01%
200
BAL
9634
DELISTED
iPath Series B Bloomberg Cotton Subindex Total ReturnSM ETN
BAL
$2K ﹤0.01%
+25
New +$2.04K
JJS
9635
DELISTED
iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN
JJS
$2K ﹤0.01%
+39
New +$2.6K
PHGE.WS
9636
DELISTED
BiomX Inc. Warrants to purchase one-half of a share of Common Stock
PHGE.WS
$2K ﹤0.01%
51,557
+1,183
+2% +$130
BDXB
9637
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
$2K ﹤0.01%
34
EUCRU
9638
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
$2K ﹤0.01%
199
-600
-75% -$5.96K
BMAQU
9639
DELISTED
Blockchain Moon Acquisition Corp. Units
BMAQU
$2K ﹤0.01%
221
-31
-12% -$314
DMYS.WS
9640
DELISTED
dMY Technology Group, Inc. VI Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
DMYS.WS
$2K ﹤0.01%
+6,835
New +$3.47K
CDAK
9641
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$2K ﹤0.01%
+616
New +$2.16K
VLTA.WS
9642
DELISTED
Volta Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50 per share
VLTA.WS
$2K ﹤0.01%
+6,058
New +$3.48K
ISEM
9643
DELISTED
Invesco Exchange-Traded Self-Indexed Fund Trust Invesco RAFI Strategic Emerging Markets ETF
ISEM
$2K ﹤0.01%
+100
New +$2.46K
MSDAW
9644
DELISTED
MSD Acquisition Corp. Warrant
MSDAW
$2K ﹤0.01%
7,514
-170
-2% -$85
CUEN
9645
DELISTED
Cuentas Inc. Common Stock
CUEN
$2K ﹤0.01%
277
-166
-37% -$1.9K
ISO
9646
DELISTED
IsoPlexis Corporation Common Stock
ISO
$2K ﹤0.01%
1,063
-1,132
-52% -$2.63K
RAAS
9647
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
$2K ﹤0.01%
508
-1,189
-70% -$3.83K
KRBP
9648
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$2K ﹤0.01%
172
-528
-75% -$8.33K
ESM.U
9649
DELISTED
ESM Acquisition Corporation Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
ESM.U
$2K ﹤0.01%
174
-1,342
-89% -$13.2K
IONM
9650
DELISTED
Assure Holdings Corp. Common Stock
IONM
$2K ﹤0.01%
4
+3
+300% +$3.45K

Similar funds

UBS Group's Q2 2022 Portfolio in Review

As of Q2 2022, UBS Group held 11,816 positions worth $244B, down 19% from $300B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group withdrew a net $9.23B in Q2 2022, closing 1,051 positions and reducing 5,058 holdings. Its most notable exit was Cerner Corp, an estimated $177M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS Group opened a new position in iShares 0-3 Month Treasury Bond ETF worth $13.8M.

  • UBS Group's largest Q2 2022 buy was iShares 0-3 Month Treasury Bond ETF: 137,765 shares worth $13.8M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $453M increase.
  • UBS Group's biggest Q2 2022 reduction was Apple, cutting an estimated $641M.
  • UBS Group fully exited Cerner Corp in Q2 2022, selling an estimated $177M.
  • UBS Group's ten largest holdings make up 13% of its $244B portfolio in Q2 2022.
  • UBS Group opened 1,263 new positions and closed 1,051 in Q2 2022.
  • UBS Group's portfolio value fell 19% quarter-over-quarter to $244B.

Based on UBS Group's 13F filing for Q2 2022, filed 10 Aug 2022.